TUCK TALHIA enters MIRA PHARMACEUTICALS, INC. with 20K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 8/2/2023ACC: 0000897069-23-001068
20K
Baseline shares
100% direct
20K
Direct ownership
1 position
30K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned20K
Total
20K direct20K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 20K | Direct |
| Total | 20K | 20K direct |
Derivative Holdings2
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
10K
Shares owned
N/A
Exercise price
5
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
20K
Shares owned
N/A
Exercise price
5
Expiration
—
Exercise window
—
Total
Underlying
30K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 5 | — | — | 10K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 5 | — | — | 20K | N/A |
| Total | 30K | 0.00 | ||||